RT Journal Article
SR Electronic
T1 Anti-retroviral therapy and serum protein levels in HIV-1 seropositive patients: a five-year retrospective study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.23.20129338
DO 10.1101/2020.06.23.20129338
A1 Akor Egbunu Shedrac
A1 Musa Haruna
A1 Eneojo-Abah Eleojo Gloria
A1 Yisa Benjamin Nma
A1 Emmanuel Friday Titus
A1 Dickson Achimugu Musa
A1 Joel Ikojo Oguche
A1 Serah Shaibu
A1 Salami Tijani
A1 David Bukbuk
A1 Samuel Eneọjọ Abah
YR 2020
UL http://medrxiv.org/content/early/2020/06/24/2020.06.23.20129338.abstract
AB Background Serum proteins designated as liver function biomarkers are used to evaluate patients for hepatic dysfunction. Hepatic effect of Anti-Retroviral Therapy (ART) needs further studies in HIV mono-infected patients. In this study, clinically defined patient datasets were analysed for protein levels in HIV-1 mono-infected seropositive patients with and without ART.Materials and Methods Data were collected for the study groups, consisting of the control group and HIV-1 mono-infected seropositive patients with and without ART and were analysed statistically for differences among the groups. All subjects in the patient groups attended University of Maiduguri Teaching Hospital, Nigeria for a period of 5 years.Result The protein levels on initiation of ART were significantly higher than baseline levels (prior to ART). However, continuous use of ART for 5-year period did not induce any further significant change in protein levels. Receiver Operating Characteristic (ROC) curves shows that both Albumin (ALB) and Total protein (TP) levels discriminated among the study groups. The baseline levels of ALB in seropositive patients are significantly lower to levels on initiation of ART.Conclusion Continuous ART did not cause any further significant change in levels of liver function proteins than was observed on ART initiation. Hence, liver damage on continuous ART is not implied. Both ALB and TP levels could be important in HIV management of patients. Initiation of ART appears to elevate the low ALB level via a yet unknown mechanism and indicates possible role of ALB in ART mechanism of action.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis is not a funded projectAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:EBIHA Virtual Research and Training The Research and Ethical Committee at the University of Maiduguri Teaching Hospital(UMTH)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData available on demand